Streetbeat News

Products Services

NVDA

NVIDIA CEO Jensen Huang expressed optimism about the company's growth, highlighting that NVIDIA's GPUs, CPUs, networking, AI foundry services, and AI Enterprise software are key growth drivers. He also emphasized the burgeoning era of generative AI.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 9:22 pm

LBPH

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) is presenting new data on LP352, a treatment for seizures associated with Developmental and Epileptic Encephalopathies (DEEs), at the 2023 AES Annual Meeting. The company is showcasing posters on LP352's drug interactions, pharmacokinetics, and pharmacodynamics, and hosting a scientific exhibit to discuss the ongoing PACIFIC study and Phase 3 program plans. Dr. Randall Kaye highlighted LP352's potential as a best-in-class therapy and Longboard's commitment to advancing treatment for rare seizure disorders.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 9:04 pm

NVDA

Starfield's patch 1.8.86 introduces DLSS support for Nvidia graphics cards, graphical options, bug fixes, and gameplay improvements for PC and Xbox Series X/S. DLSS Super Resolution and Nvidia Reflex Low Latency are now available, enhancing performance and reducing latency. The update also adds instant food consumption, brightness and contrast sliders, HDR settings, and addresses performance issues like memory leaks and GPU optimizations. Gameplay adjustments and quest-related fixes are included to improve overall experience.

Portfolio Pulse from Franca Quarneti

November 21, 2023 | 9:02 pm

IVA

Inventiva reported its financial results for Q3 2023, with cash and equivalents at €43.8M, short-term deposits at €0.03M, and long-term deposits at €5M as of September 30, 2023. Revenue for the first nine months was €1.9M, a significant increase from €0.1M in the same period in 2022. The company's cash runway is expected to extend to Q3 2024, subject to conditions of the EIB loan's second tranche. Inventiva's R&D expenses increased by 86% due to clinical trials for NASH treatment. The company also entered into a licensing agreement with Hepalys Pharma for lanifibranor in Japan and South Korea, receiving a $10M upfront payment and potential for $231M in milestones plus royalties.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 9:02 pm

NVO

Novo Nordisk A/S (NYSE:NVO) is facing a significant surge in demand for its diabetes drug Ozempic (semaglutide) and will restrict its starter kit supplies in Europe. The company will also temporarily reduce the supply of another diabetes drug, Victoza (liraglutide), to focus on Ozempic production. Intermittent shortages of Ozempic are expected through 2024, with Victoza shortages lasting until Q2 2024. Novo Nordisk advises against starting new patients on Victoza until supplies normalize and to limit new patient initiations on Ozempic. The company announced a DKK 42 billion investment to expand manufacturing in Denmark, including for GLP-1 products like Ozempic. Novo Nordisk's stock is slightly down by 0.31% at $103.24.

Portfolio Pulse from Vandana Singh

November 21, 2023 | 8:30 pm

MSFT

Microsoft is preparing for the potential arrival of OpenAI employees by readying office space and resources in LinkedIn's San Francisco offices. This follows the announcement that Sam Altman and Greg Brockman are joining Microsoft to lead a new AI research team. Microsoft was surprised by Altman's firing from OpenAI but is open to him returning if the board is reconstituted. The company is setting up workspaces and providing legal and HR support for onboarding, and promises similar compensation for OpenAI employees joining Microsoft.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 8:09 pm

AMZN

MSFT

NVDA

Evercore ISI analyst Mark Mahaney predicts that Amazon.com Inc (AMZN) stock will trade at $200 in 2024, driven by growth in AI applications in cloud computing, advertising, and retail. Mahaney suggests that the market has not fully recognized Amazon's AI potential, which he believes will lead to record operating margins and profit next year. Despite a recent uptick, he views the current stock price as a dislocated buying opportunity. Meanwhile, shares of Microsoft (MSFT) and Nvidia (NVDA) were bid up in 2023 due to their AI exposure.

Portfolio Pulse from Adam Eckert

November 21, 2023 | 7:39 pm

FSLR

MAXN

SEDG

SHLS

Mizuho Securities analysts initiated coverage on First Solar, SolarEdge, Shoals Technologies, and Maxeon Solar Technologies with price targets. They are bullish on FSLR, SEDG, and SHLS, citing strong market positions, innovative technologies, and growth opportunities. FSLR is noted for its sold-out status through 2026 and potential for margin improvement. SEDG is recognized for its market diversification and attractive valuation. SHLS is praised for its rapid growth and expansion into new product areas. MAXN is given a neutral rating due to premium pricing and competitive challenges.

Portfolio Pulse from Shivani Kumaresan

November 21, 2023 | 7:24 pm

GEO

MSFT

Citron Research tweeted that GEO Group, Inc. (GEO) should see its stock price return to $15 as investors recognize it as the sole provider of a Congressional-approved technology solution for tracking migrants, a service not offered by Microsoft (MSFT).

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 7:23 pm

AMZN

SONY

WMT

For Black Friday, Sony Group Corp. is offering discounts on PlayStation memberships and gift cards. Amazon.com is providing a 10% discount on $30 and $70 PlayStation Plus gift cards, while Walmart is discounting all PlayStation Gift Cards by 10%, with a special deal on the $110 card for $99. PS Plus subscriptions are also discounted by up to 30% until Nov. 27.

Portfolio Pulse from Franca Quarneti

November 21, 2023 | 6:48 pm